Report Highlights
The global market for telemedicine technologies is estimated to increase from $72.4 billion in 2022 to reach $173.3 billion by 2027, with a compound annual growth rate (CAGR) of 19.1% from 2022 through 2027.
Report Includes
- 47 data tables and 44 additional tables
- An up-to-date review and analysis of the global markets for telemedicine technologies
- Analyses of the global market trends, with historic market revenue (sales data) from 2019 to 2021, estimates for 2022, and projections of compound annual growth rates (CAGRs) through 2027
- Highlights of the current and future market potential for telemedicine technologies, and areas to forecast this market into various segments and sub-segments
- Estimation of the actual market size (value based) for global telemedicine market in USD million terms, market forecast, and corresponding market share analysis by business segment (component), application, end user, and geographic region
- Market assessment of the telemedicine products and technologies currently available, new developments, spending trends, and revenue prospects for this innovation driven market
- Discussion of the telemedicine industry value chain analysis providing a systematic study of the key intermediaries involved, which could further assist stakeholders in formulating appropriate strategies
- Updated information on key developments, mergers and acquisitions (M&A) activities, collaborations, joint ventures and partnerships in the telemedicine industry.
- Identification of the major stakeholders and analysis of the competitive landscape based on recent developments and segmental revenues
- Descriptive company profiles of the leading global players, including Allscripts Healthcare Solutions Inc., Boston Scientific Corp., Cerner Corp., Cisco Systems Inc., GE Healthcare, Medtronic, Philips Healthcare and Siemens Healthcare
Report Scope
The scope of this report is broad and covers the components available in the telemedicine market and potential end-user applications. Revenue forecasts from 2022 to 2027 are given for components, applications and end-users with estimated value derived from the revenues of manufacturers.
The report also includes a discussion on the major players in each regional telemedicine market. Further, it explains major drivers and regional dynamics of the global telemedicine market. The report concludes with a look at the vendor landscape and includes detailed profiles of major vendors in the global telemedicine market.
Report Synopsis
| Report Metrics | Details | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Base year considered | 2021 | ||||||||||||||||||||
| Forecast period considered | 2022-2027 | ||||||||||||||||||||
| Base year market size | $60.9 billion | ||||||||||||||||||||
| Market size forecast | $173.2 billion | ||||||||||||||||||||
| Growth rate | CAGR of 19.1% from 2022 to 2027 | ||||||||||||||||||||
| Units considered | $ Millions | ||||||||||||||||||||
| Segments covered | Business Segment, End User, Application | ||||||||||||||||||||
| Regions covered | North America, Europe, Asia-Pacific, Rest of the World (RoW) | ||||||||||||||||||||
| Countries covered | United States, Canada, France, Germany, U.K., Spain, Rest of Europe, China, India, Japan, Rest of Asia-Pacific | ||||||||||||||||||||
| Companies studied |
|
||||||||||||||||||||
Analyst Credentials
BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.
- Siemens: 360° Company Analysis (IFT322A)
- Thermo Fisher Scientific Inc.: 360° Company Analysis (HLC309A)
- Needle-Free Devices: Technologies and Global Markets (HLC178C)
- Koninklijke Philips N.V.: 360° Company Analysis (HLC308A)
- Global High Purity Quartz Market (CHM191A)
Related Reports
Digital Pathology: Technologies and Global Markets
The global digital pathology market is expected to grow from $7.8 billion in 2024 and is projected to reach $13.7 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.9% during the forecast period of 2024 to 2029.
2024 Robotics Technology Research Review
This 2024 Research Review of Robotics Technology Market provides a sampling of the type of quantitative market information, analysis, and guidance that BCC Research has been developing since its inception in 1971 to help its customers make informed business decisions.
OTC Drugs, Medical Devices and Diagnostics: Global Markets
The global market for OTC drugs, medical devices, and diagnostics is estimated to increase from $251.7 billion in 2024 to reach $359.7 billion by 2029, at a compound annual growth rate (CAGR) of 7.4% from 2024 through 2029.
Chronic Disease Management: Therapeutics, Device Technologies and Global Markets
The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.
Track the Latest Global Tariff Developments
In today's fast-paced global economy, tariffs are no longer static—they are dynamic levers shaped by geopolitical realignments, supply chain vulnerabilities, inflationary pressures, and sustainability-driven trade reforms. As governments worldwide recalibrate their trade strategies, businesses are left to navigate a maze of shifting rules, rising costs, and regulatory uncertainty.
Our analysis empowers you with real-time updates and in-depth expert analysis on all facets of global tariff activity. From new trade agreements and sanctions to abrupt tariff hikes and retaliatory duties, we monitor developments across borders, sectors, and industries—so you don't have to.
Whether it's the ongoing U.S.–China trade dynamics, the evolving EU Carbon Border Adjustment Mechanism (CBAM), or the emerging policies in India, ASEAN, and Latin America, we provide full-spectrum coverage. We also track multilateral trade negotiations, World Trade Organization (WTO) rulings, and sector-specific duty structures—ensuring you are always ahead of global trade shifts.
With our analysis, you can stay informed, identify risks, and confidently respond to tariff changes—no matter where you operate.
Ready to see what tariff means for your business?
Consult with our experts or request your custom Tariff Impact Brife today
Stay Informed, Stay Competitive
In today's interconnected and unpredictable global economy, staying ahead of tariff shifts is not just important—it's essential. BCC Research provides decision-makers with trusted, research-driven insights that turn uncertainty into opportunity.
Our in-depth market analysis and trade intelligence help you decode how tariff changes impact your specific sector—manufacturing, healthcare, technology, agriculture, or energy. We break down complex data into actionable knowledge through comprehensive reports, expert commentaries, and sector-focused forecasts.
Our analysis includes:
- Thorough breakdowns of current and proposed tariff policies and how they affect regional and global trade flows.
- Sector-specific implications, helping you understand the strategic impact on sourcing, pricing, and competitiveness.
- Forward-looking insights to support risk management, planning, and response strategies for evolving trade conditions.
With BCC Research, you gain more than just information—you gain clarity and confidence to make well-informed decisions in a volatile trade environment.
Don't let tariffs catch you off guard—let our insights guide your strategy.
Recent Reports
Thermo Fisher Scientific Inc.: 360° Company Analysis
This report provides a comprehensive analysis of Thermo Fisher Scientific Inc., covering key details such as key milestones/history, product offerings, technologies, major applications and end-user industries it serves.
Needle-Free Devices: Technologies and Global Markets
The global market for needle-free devices was valued at $15.5 billion in 2024 and is estimated to increase from $17.0 billion in 2025 to reach $27.7 billion by 2030, at a compound annual growth rate (CAGR) of 10.2% from 2025 through 2030.
Koninklijke Philips N.V.: 360° Company Analysis
The report discusses a 360° analysis of Koninklijke Philips N.V. It covers various aspects of Koninklijke Philips N.V., including products, business segments, history, distributors, and financial and strategic development.
Global Thyroid Gland Disorders: Diagnostics and Treatment Market
The global market for diagnostics and treatment of thyroid gland disorders was valued at $15.5 billion in 2024 and is estimated to increase from $16.3 billion in 2025 to reach $21.0 billion by 2030, at a compound annual growth rate (CAGR) of 5.2% from 2025 through 2030.
Global Outpatient Clinics Market
The global outpatient clinics market is expected to grow from $4.4 trillion in 2024 and is projected to reach $6.3 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 7.6% during the forecast period of 2024 to 2029.
Top Trending Reports
Next-Generation Advanced Batteries: Global Markets
The global market for next-generation advanced batteries is estimated to grow from $1.5 billion in 2024 to reach $5.3 billion by the end of 2029, at a compound annual growth rate (CAGR) of 28.5% from 2024 through 2029.
Global Pharmaceutical Drugs Industry: Competitive Landscape 2023
This report discusses the global pharmaceutical drugs industry and its competitive landscape in terms of significant player market ranking and top pharmaceutical drugs. Company profiles of the top 50 pharmaceutical companies, innovative products and technologies, trends and market dynamics, competitive intelligence, and regional trends are well-researched and analyzed in this report.
Global Markets and Manufacturing Technologies for Protein Drugs
The global protein drugs market is expected to grow from $441.7 billion in 2024 and is projected to reach $655.7 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.2% during the forecast period of 2024 to 2029.
Biologic Therapeutic Drugs: Technologies and Global Markets
The global market for biologic therapeutic drugs is estimated to increase from $499.2 billion in 2024 to reach $794.5 billion by 2029, at a compound annual growth rate (CAGR) of 9.7% from 2024 through 2029.
Global Markets for Emerging Medical Device Technologies
The global market for emerging medical devices is estimated to increase from $136.6 billion in 2024 to reach $223.9 billion by 2029, at a compound annual growth rate (CAGR) of 10.4% from 2024 through 2029.
Report Highlights
The global telemedicine market should grow from $43.2 billion in 2019 to $104.0 billion by 2024, at a compound annual growth rate (CAGR) of 19.1% during the forecast period of 2019-2024.
Report Includes
- 49 data tables and 42 additional tables
- An overview of the global markets for telemedicine technologies within the industry
- Analyses of the global market trends, with data corresponding to market size for 2018 and 2019, and projections of compound annual growth rates (CAGRs) through 2024
- Discussion of market opportunities and challenges, and highlights of the new telemedicine products and technologies influencing the demand for adoption of innovative medical technology
- Information pertaining to the impact of COVID-19 pandemic on the growth of the telemedicine market
- Industry value chain analysis of the telemedicine market providing a systematic study of the key intermediaries involved, which could further assist stakeholders in formulating appropriate strategies
- Key merger and acquisition deals, partnerships, collaborations and joint ventures as well as other strategic alliances in the global telemedicine market
- Market share analysis of the key market participants and their research priorities and competitive landscape
- Detailed company profiles of the major global corporations, including AMD Global Telemedicine, Boston Scientific Corp., GE Healthcare, Medtronic, Inc., Resideo Life Care Solutions and Siemens Healthcare
Report Highlights
The global telemedicine market totaled $31.2 billion in 2018 and is estimated to reach $72.5 billion by 2023, growing at a compound annual growth rate (CAGR) of 18.3% for the period of 2018-2023.
Report Includes
- 24 data tables and 26 additional tables
- An overview of the global telemedicine market
- Country specific data and analysis for United States, Canada, Mexico, UK, France, Germany, China, India, Japan, Brazil, South Africa and GCC Countries
- Detailed description of telemedicine hardware providers, software providers, telecom and networking companies, healthcare companies, and health insurance providers
- Evaluation of the potential role of telemedicine to improve collaborative healthcare status
- Identification of new technological developments and latest business trends developing in the telemedicine market
- Comprehensive company profiles of key players in the market, including IBM Corp., Medtronic Inc., Siemens Healthcare, Agfa HealthCare NV and BioTelemetry Inc.
Report Highlights
The global telehome and telehospital/clinic market is expected to grow from nearly $23.8 billion in 2016 to roughly $55.1 billion by 2021, with a compound annual growth rate (CAGR) of 18.3% for the period of 2016-2021.
Report Includes
- An in-depth analysis of the global telemedicine market.
- Analyses of global market trends, with data from 2015, estimates for 2016, and projections of compounds annual growth rates (CAGRs) through 2021.
- Coverage of telemedicine hardware providers, software providers, telecom and networking companies, healthcare companies, health insurance providers, and many more.
- Detailed analysis of telemedicine applications.
- Explorations into the ways in which collaborative healthcare can be better and more economically implemented through telemedicine.
- Examination of the new technological developments as well as the latest business trends developing in the telemedicine market.
- Profiles of key players in the market.
Report Highlights
The global telehospital/clinic and telehome market reached $16.3 billion in 2013 and $19.2 billion in 2014, and should reach about $43.4 billion in 2019 with a compound annual growth (CAGR) of 17.7% through 2019.
Report Includes
- An in-depth analysis of the global telemedicine market.
- Analyses of global market trends, with data from 2013, estimates for 2014, and projections of compounds annual growth rates (CAGRs) through 2019.
- Coverage of telemedicine hardware providers, software providers, telecom and networking companies, healthcare companies, health insurance providers, and many more.
- Explorations into the ways in which collaborative healthcare can be better and more economically implemented through telemedicine.
- Examination of the new technological developments as well as the latest business trends developing in the telemedicine market.
- Comprehensive company profiles of key players in the market.
Report Highlights
The global telehome and telemedicine market reached $13.8 billion 2012. This market is expected to grow to $16.1 billion 2013 and $35.1 billion in 2018 with a compound annual growth (CAGR) of 16.9%.
Report Includes
- An in-depth analysis of the global telemedicine market.
- Analyses of global market trends, with data from 2012, estimates for 2013, and projections of compounds annual growth rates (CAGRs) through 2018.
- Coverage of telemedicine hardware providers, software providers, telecom and networking companies, healthcare companies, health insurance providers, and many more.
- Explorations into the ways in which collaborative healthcare can be better and more economically implemented through telemedicine.
- Examination of the new technological developments as well as the latest business trends developing in the telemedicine market.
- Comprehensive company profiles of key players in the market.
Report Highlights
The global telemedicine market is expected to grow from $9.8 billion in 2010 to $11.6 billion in 2011, and to $27.3 billion in 2016, a compound annual growth rate (CAGR) of 18.6% over the next five years.
Report Highlights
The global telemedicine market is expected to grow from $9.8 billion in 2010 to $23 billion in 2015, at a compound annual growth rate (CAGR) of 18.6% over the next 5 years.
Report Highlights
-
The global market for telemedicine increased from $4.8 billion in 2006 to an estimated $5.8 billion in 2007. It should reach $13.9 billion by 2012, a compound annual growth rate (CAGR) of 19%.
-
The telehome market currently accounts for 22% of the market and is expected to capture almost 37% of the telemedicine market by 2012.
-
The telemedicine service market is expected to grow from $3.6 billion in 2007 to $8.3 billion in 2012, mainly driven by the telehospital service market.
Report Highlights
-
The current level of telemedicine expenditures is about $4.33 billion.
-
These expenditures will experience an AAGR of 9.7% from 2002 to 2007.
-
Procurement will continue to be the lead spending category through 2007.
-
In 2007, it will account for a total of $2.16 billion, or about 31% of all spending.
-
Fastest growth in technology spending will be software, at an AAGR of 12.9%.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More